Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
99 100 Next >
Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
Via MarketBeat
Topics Government
Exposures COVID-19 Political Product Safety
Tickers AZN HIMS LLY PFE
Caballeta Bio Shares Surge The Most In 23 Months In A Single Day As It Unveils Plan To Meet FDA By 2025 For Systemic Sclerosis Drug Trial
Via Benzinga
Exposures Product Safety
Tickers CABA
2 Generic Drug Stocks Ready to Surge in 2025
Via MarketBeat
Topics Government Intellectual Property
Exposures Intellectual Property Political Product Safety
Tickers AMGN LXRX PFE TEVA
Bird Flu Found In Raw Milk Leads To Recall In California
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers GSK MRNA SNY
Marijuana Recalls in California Underscore Importance of Decontamination
Via Investor Brand Network
Topics Cannabis Product Recall
Exposures Cannabis Legal Product Safety
CCHR Urges FDA Overhaul to End Psychiatric Drug and Device Harms
Via PRLog
Exposures Product Safety
Why Hims & Hers Stock Jumped on Massive FDA News
Via The Motley Fool
Exposures Product Safety
Tickers HIMS
InvestorkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) COO to Present at NobleCon20 Emerging Growth Conference
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Presents Progress in Pivotal Study of Berubicin for Glioblastoma Treatment
Via Investor Brand Network
Exposures Product Safety
Tickers CNSP
FDA Approves BridgeBio Pharma's Drug For Rare Heart Disease, Poised To Challenge Pfizer In Lucrative Yet Competitive Market
Via Benzinga
Exposures Product Safety
Tickers BAYRY BBIO PFE
HUMA DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before January 17, 2025
Via TheNewswire.com
Exposures Product Safety
HUMACYTE DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on January 17, 2025
Via TheNewswire.com
Exposures Product Safety
AstraZeneca's Andexxa Faces FDA Scrutiny Over Effectiveness, Safety Concerns
Via Benzinga
Exposures Product Safety
Tickers AZN
HUMA Deadline to Lead in Securities Fraud Lawsuit is January 17, 2025 - Contact Kaplan Fox &amp; Kilsheimer LLP
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
FDA Greenlights Jazz Pharma's Cancer Drug, A Milestone For Zymework
Via Benzinga
Exposures Product Safety
Tickers JAZZ ZYME
Nikola Recalls Dozens of its Trucks as Defective Display Raises Possibility of Crashes
Via Investor Brand Network
Topics Electric Vehicles Product Recall
Exposures Electric Vehicles Legal Product Safety
Tickers NKLA
FDA Approves Cannabis Trial For Veterans With PTSD After Years Of Delays
Via Benzinga
Topics Cannabis
Exposures Cannabis Product Safety
FDA Approves UCB's Psoriasis Drug For Expanded Use In Painful Inflammatory Skin Disease
Via Benzinga
Exposures Product Safety
Tickers UCBJF UCBJY
National Law Firm Parker Waichman Discusses The Financial Impact Of A Tracheostomy Tube Defect Injury
Via Prodigy
Topics Death
Exposures Death Product Safety
CJ Biomaterials Completes Trials of New PHACT PHA Grade for Use by Straw Manufacturers Seeking Marine Degradability Certification
Via Newsfile
Exposures Product Safety
New Single “Pike County Coal” Delivers Heartbreaking Tale of Labor, Loss, and Regret
Via AB Newswire
Topics Product Recall
Exposures Coal Legal Product Safety
Kaplan Fox &amp; Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025
Via TheNewswire.com
Exposures Product Safety
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) COO to Present at Winter 2024 Investor Summit
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
Marijuana Recalls in California Underscore Importance of Decontamination
Via CannabisNewsWire
Topics Cannabis Product Recall
Exposures Cannabis Legal Product Safety
Tickers TSNDF TSX:TSND
CCHR Urges FDA to Finalize Its Proposed Ban of Electric Shocking Device Used on Autistic and Disabled Students
Via Press Release Distribution Service
Exposures Product Safety
ClearSight Highlights the Proven Safety and High Success of SMILE Eye Surgery in New Article
Via Press Advantage
Exposures Product Safety
Ispire And IKE Tech Advance FDA-Backed Age Verification Tech To Curb Youth Vaping
Via Benzinga
Exposures Product Safety
Tickers ISPR
Dave Ramsey Recalls The Day American Express Called His Wife, Asking Why Stay 'With A Man That Won't Pay His Bills.' Here's What He Did Next
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers AXP
BioMedNewsBreaks — Silo Pharma Inc. (NASDAQ: SILO) Promising Preclinical Results for SPC-15 in Treating Severe Psychiatric Disorders
Via Investor Brand Network
Exposures Product Safety
Tickers SILO
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Highlights Phase 3 Success for TNX-102 SL in Fibromyalgia Treatment
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.